Enteral administration of alectinib for ALK-positive non-small cell lung cancer in an elderly patient

20216 citationsJournal Articlegold Open Access

Authors

Quentin Dominique Thomas · Université de Montpellier

Marie Pautas · Université Paris-Saclay

Marie-Noëlle Guilhaume · Université Paris-Saclay

Frédéric Fiteni · Centre Hospitalier Universitaire de Nîmes

Ting Ge · Université Paris-Saclay

Nicolas Girard · Université Paris-Saclay

Abstract

In cases of lung cancer with oncogenic addiction, enteral administration of TKIs should be considered for elderly patients with an impaired general condition.

Topics & Keywords

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Neuroendocrine Tumor Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Medicine

Volume 100, Issue 43, pp. e27611-e27611

DOI: 10.1097/md.0000000000027611

Field-Weighted Citation Impact: 0.44